Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nature‐Inspired Multifunctional Ligands: Focusing on Amyloid‐Based Molecular Mechanisms of Alzheimer's Disease
Elena Simoni, Melania Maria Serafini, Manuela Bartolini, et al.
ChemMedChem (2015) Vol. 11, Iss. 12, pp. 1309-1317
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 479
Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea
Michele Catanzaro, Emanuela Corsini, Michela Rosini, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2778-2778
Open Access | Times Cited: 235
Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?
Melania Maria Serafini, Michele Catanzaro, Michela Rosini, et al.
Pharmacological Research (2017) Vol. 124, pp. 146-155
Closed Access | Times Cited: 101
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease
J Jerábek, Elisa Uliassi, Laura Guidotti, et al.
European Journal of Medicinal Chemistry (2016) Vol. 127, pp. 250-262
Closed Access | Times Cited: 98
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 45
Novel 8‐Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer′s Disease
Federica Prati, Christian Bergamini, Romana Fato, et al.
ChemMedChem (2016) Vol. 11, Iss. 12, pp. 1284-1295
Closed Access | Times Cited: 77
Multitarget Strategies in Alzheimer’S Disease: Benefits and Challenges on the Road to Therapeutics
Michela Rosini, Elena Simoni, Roberta Caporaso, et al.
Future Medicinal Chemistry (2016) Vol. 8, Iss. 6, pp. 697-711
Closed Access | Times Cited: 73
Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids
Melania Maria Serafini, Michele Catanzaro, Francesca Fagiani, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 63
Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases
Marjan Talebi, Mohsen Talebi, Eleni Kakouri, et al.
International Journal of Biological Macromolecules (2021) Vol. 172, pp. 93-103
Closed Access | Times Cited: 30
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy
Marialuigia Fantacuzzi, Rosa Amoroso, Simone Carradori, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114242-114242
Closed Access | Times Cited: 22
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer’s Disease: A Rational Approach
Elena Simoni, Melania Maria Serafini, Roberta Caporaso, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 7, pp. 1618-1627
Closed Access | Times Cited: 37
NRF2 and PPAR-γ Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell Differentiation
Chiara De Nuccio, Antonietta Bernardo, Carmen Troiano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7216-7216
Open Access | Times Cited: 31
Gramine Derivatives Targeting Ca2+ Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases
Rocío Lajarín-Cuesta, Carmen Nanclares, Juan-Alberto Arranz-Tagarro, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 13, pp. 6265-6280
Open Access | Times Cited: 29
Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases
Andrea Bacci, Massimiliano Runfola, Simona Sestito, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 367-367
Open Access | Times Cited: 21
Eye-Light on Age-Related Macular Degeneration: Targeting Nrf2-Pathway as a Novel Therapeutic Strategy for Retinal Pigment Epithelium
Michele Catanzaro, Cristina Lanni, Filippo Basagni, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 23
Hydroxy-substituted trans -cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease
Angela De Simone, Manuela Bartolini, Andrea Baschieri, et al.
European Journal of Medicinal Chemistry (2017) Vol. 139, pp. 378-389
Closed Access | Times Cited: 24
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease
Elena Simoni, Roberta Caporaso, Christian Bergamini, et al.
ACS Medicinal Chemistry Letters (2016) Vol. 7, Iss. 12, pp. 1145-1150
Open Access | Times Cited: 17
Lights and Shadows of Electrophile Signaling: Focus on the Nrf2-Keap1 Pathway
Filippo Basagni, Cristina Lanni, Anna Minarini, et al.
Future Medicinal Chemistry (2019) Vol. 11, Iss. 7, pp. 707-721
Closed Access | Times Cited: 14
Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds
Francesca Fagiani, Michele Catanzaro, Erica Buoso, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 14
Computational Study of the Aza‐Michael Addition of the Flavonoid (+)‐Taxifolin in the Inhibition of β‐Amyloid Fibril Aggregation
Tiziana Ginex, Marta Trius‐Soler, F. Javier Luque
Chemistry - A European Journal (2018) Vol. 24, Iss. 22, pp. 5813-5824
Closed Access | Times Cited: 14
Nature-Inspired Hybrids (NIH) Improve Proteostasis by Activating Nrf2-Mediated Protective Pathways in Retinal Pigment Epithelial Cells
Ali Koskela, Federico Manai, Filippo Basagni, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1385-1385
Open Access | Times Cited: 7
Inhibition of β-Amyloid Aggregation in Alzheimer’s Disease: The Key Role of (Pro)electrophilic Warheads
Filippo Basagni, Marina Naldi, Tiziana Ginex, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 11, pp. 1812-1818
Open Access | Times Cited: 6
Association of tripartite motif family-like 2 (TRIML2) polymorphisms with late-onset Alzheimer’s disease risk in a Korean population
Won Sub Kang, Jin Kyung Park, Young Jong Kim, et al.
Neuroscience Letters (2016) Vol. 630, pp. 127-131
Closed Access | Times Cited: 6
A Nature-Inspired Nrf2 Activator Protects Retinal Explants from Oxidative Stress and Neurodegeneration
Maria Grazia Rossino, Rosario Amato, Marialaura Amadio, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1296-1296
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top